News
Key mechanism identified for reducing chronic inflammation in cardiovascular diseases
A breakthrough discovery in understanding how white blood cells move in the body could pave the way for new treatments.
-
Study highlights new vaccine’s early effectiveness against TB
A study by the Centenary Institute has revealed how a new mucosal (nasal delivered) vaccine can provide early protection against tuberculosis (TB) by drawing a particular type of immune cell into the lungs.News Type: Research NewsDate -
Blood vessel breakdown linked with Alzheimer’s disease
Researchers at the Centenary Institute have discovered a connection between the health of blood vessels and the development of Alzheimer’s disease. The findings suggest that early interventions aimed at improving blood vessel health offer an avenue for the advancement of new treatments for Alzheimer’s. A progressive brain disorder, Alzheimer’s disease causes memory loss, cognitive decline ...News Type: Media releaseDate -
Research to unlock the secrets of muscle loss in ageing
The Centenary Institute and the University of Technology Sydney will lead pioneering research into age-related muscle loss, called sarcopenia, with a Dynamic Resilience Program contract from Wellcome Leap.News Type: Media releaseDate -
New treatment offers hope for advanced liver cancer
Researchers have discovered a new way to treat hepatocellular carcinoma (HCC), the most common type of liver cancer and the third leading cause of cancer death worldwide.News Type: Media releaseDate -
Meet Dr Bobby Boumelhem
Dr Bobby Boumelhem, a dedicated researcher at the Centenary Institute, is on a mission to enhance the quality of life for individuals grappling with liver disease. Diseases such as hepatitis, liver cancer, non-alcoholic fatty liver disease and cirrhosis pose significant health challenges.News Type: ProfilesDate -
Cancer drug for COVID-19
Researchers, including Dr Matt Johansen from the Centenary UTS Centre for Inflammation and Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, have discovered that a cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients.News Type: Research NewsDate -
Centenary Institute supports the Voice
As a medical research institute deeply committed to improving the health outcomes of all Australians, the Centenary Institute wholeheartedly endorses the principles of voice, treaty, and truth, and gives its full support to the Voice to Parliament.News Type: InstituteDate -
Link between gut bacteria and long-term COVID-19 effects revealed
Researchers, including from the Centenary Institute, have highlighted a potential link between gut microbiota (the collection of bacteria residing in the digestive system) and enduring health problems experienced by individuals who have recovered from COVID-19.News Type: Research NewsDate -
‘When Art Meets Science’ image winners announced
The Centenary Institute has announced the winning images of its 'When Art Meets Science' exhibition with Dr Kieran English earning the top spot in the judged category for his portrayal of T cells, an important part of the immune system.News Type: InstituteDate -
Dr Tiffen provides insight at leadership event
Dr Jessamy Tiffen, Head of the Centenary Institute’s Epigenetics of Melanoma Program, has been an invited panel guest at a special leadership event hosted by the law firm Jones Day.News Type: EventsDate -
Professor Hansbro features on the Good Reading podcast
Professor Phil Hansbro, Director of the Centenary UTS Centre for Inflammation, has been interviewed on the Good Reading podcast about his recently published book, ‘The Good Gut Anti-Inflammatory Diet’.News Type: Media coverageDate -
Centenary Institute signs-up to openness agreement on animal research
The Centenary Institute has pledged its commitment to greater transparency in the use of animals for medical research, becoming a signatory of the Openness Agreement on Animal Research and Teaching in Australia.News Type: InstituteDate